super bowl of Biotechs

Collapse
This topic is closed.
X
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Duniyo
    Senior Member
    • Oct 2010
    • 199

    super bowl of Biotechs

    October is here and it's make it or break it for many small biotech companies. I am looking at AVNR, BIOD, and ALXA at the moment.

    AVNR has good chance of approval while ALXA and BIOD are in doubts. Personally I think BIOD will be reject considering they ignore to correct the anomalies in their data.

    Any of you guys into Biotechs?
  • dmk112
    Senior Member
    • Nov 2004
    • 1759

    #2
    check out this thread http://www.mrmarketishuge.com/showth...t=2821&page=13
    http://twitter.com/DMK112

    Comment

    • not nacho
      Junior Member
      • Jul 2010
      • 2

      #3
      Originally posted by Duniyo View Post
      October is here and it's make it or break it for many small biotech companies. I am looking at AVNR, BIOD, and ALXA at the moment.

      AVNR has good chance of approval while ALXA and BIOD are in doubts. Personally I think BIOD will be reject considering they ignore to correct the anomalies in their data.

      Any of you guys into Biotechs?
      $BIOD - Rejected on October 30? Unlikely.

      Receive a CRL on or before the 30th because of the India data seems to be the sentiment.
      A CRL should show a clear direction from the FDA about what is to be done and approval next go round.

      Long @ 3.79. I should be able to hold out till next year while adding bargain shares along the way.

      Also Long $MNKD @ 5.65 and enjoying the current BS buyout rumor. This stock was sitting for weeks trading side ways 5.99 - 6.01
      Will hold till peak of run up in December then sell out with only a small holding through the PDUFA.

      Comment

      • Karel
        Administrator
        • Sep 2003
        • 2199

        #4
        Originally posted by Duniyo View Post
        October is here and it's make it or break it for many small biotech companies. I am looking at AVNR, BIOD, and ALXA at the moment.

        AVNR has good chance of approval while ALXA and BIOD are in doubts. Personally I think BIOD will be reject considering they ignore to correct the anomalies in their data.

        Any of you guys into Biotechs?
        As there already is a thread discussing just the kind of biotechs you mention, I refer you and other interested people to RiverBabe's Baby Biotechs.

        This thread is closed.

        Regards,

        Karel
        My Investopedia portfolio
        (You need to have a (free) Investopedia or Facebook login, sorry!)

        Comment

        Working...
        X